Mitsuhiro Yuasa1, Masato Shiiba2, Daisuke Kaji1, Kosei Kageyama1, Aya Nishida1, Shinsuke Takagi1, Hisashi Yamamoto1, Yuki Mori1, Akiko Yoneyama3, Shigeyoshi Makino4, Naoyuki Uchida1, Maikiko Ishihara2, Koji Izutsu1,5, Shuichi Taniguchi1, Go Yamamoto1 (1.Hematology, Toranomon Hospital, Tokyo, Japan, 2.Dignostic Imaging Center, Toranomon Hospital, Tokyo, Japan, 3.Department of Infectious Disease, Toranomon Hospital, Tokyo, Japan, 4.Department of Transfusion Medicine, Toranomon Hospital, Tokyo, Japan, 5.Department of Hematology, National Cancer Center Hospital, Tokyo, Japan)
Session information
Oral Session
Oral Session 2-10B Indolent Lymphoma: Prognostic Factors
Sat. Oct 12, 2019 10:10 AM - 11:10 AM No.10 (Tokyo International Forum, 4F G409)
Chair: Noriko Fukuhara (Tohoku University Hospital, Department of Hematology and Rheumatology)
Koichi Watamoto, Masato Zennami, Yasuko Torii, Yumi Ishiguri, Yoshiya Adachi, Norihiro Ueda, Rika Kihara (Department of Hematology, Komaki City Hospital, Japan)
Manabu Suzuki, Shohei Ikeda, Masumi Sukegawa, Saburo Tsunoda, Masatsugu Ohta (Div. Hematology, Fukushima Medical University, Aizu Medical Center, Fukushima, Japan)
Maki Nemoto1, Norihito Inoue2, Keiich Azuma1, Toshihiro Hama1, Yasuhito Terui2 (1.Japanise Foundation for Cancer Research, Tokyo, Japan, 2.Japanise Foundation for Cancer Research, Tokyo, Japan)
Takuro Matsumoto1, Junichi Kitagawa1, Yuto Kaneda1, Kimihiro Yamaguchi1, Nobuhiko Nakamura1, Nobuhiro Kanemura1,2, Michio Sawada3, Takeshi Hara1,4, Masahito Shimizu1, Hisashi Tsurumi1,4 (1.Dept. Hematol., Gifu Univ. Grad. Sch. Med., Gifu, Japan, 2.Dept. Hematol., Chuno Kosei Hospital, Gifu, Japan, 3.Dept. Hematol., Gifu Red Cross Hospital, Gifu, Japan, 4.Dept. Hematol., Matsunami General Hospital, Gifu, Japan)
Kosuke Arai1, Keisuke Tanaka2, Yoshihiro Umezawa1, Toshikage Nagao1, Shigeo Toyota2, Osamu Miura1, Masahide Yamamoto1 (1.Hematology., Tokyo Medical and Dental University., Tokyo, Japan, 2.Department of Hematology., Yokosuka Kyosai Hospital., Tokyo., Japan)